161
Views
3
CrossRef citations to date
0
Altmetric
Choroid

The Role of C-Jun N-terminal Kinase-1 in Controlling Aquaporin-1 and Choroidal Thickness during Recovery from Form-deprivation Myopia in Guinea Pigs

, , , &
Pages 885-894 | Received 09 Sep 2020, Accepted 15 Oct 2020, Published online: 28 Oct 2020
 

ABSTRACT

Purpose

The development and recovery(REC) of myopia is associated with changing of choroidal thickness(CT) in model of guinea pigs. Aquaporin-1 (AQP-1) is related to the changes of CT during the recovery from myopia, but the corresponding signaling pathway has not been clarified. This study aimed to investigate the effect of JNK1 on CT/AQP-1 and the recovery from myopia.

Materials and Methods

According to the different single intravitreal injections in eyes that underwent form deprivation for 21 days, guinea pigs were divided into four groups: the REC group, the REC+anisomycin (REC-AN, agonist for JNK1, 0.2 nmol) group, the REC+SP600125 (REC-SP, inhibitor for JNK1, 0.2 nmol) group, and the REC+dimethyl sulfoxide (REC-DM) group. Each group was divided into three subgroups based on the duration of the form deprivation: 3 days (d), 7 d and 10 d. All animals underwent biometric measurements (refractive error, axial length (AL), and CT), and the protein expression of AQP-1 and p-JNK1 in the choroid was also measured.

Results

In REC and REC-DM groups, significant differences in CT/refractive error/AL/p-JNK1 or AQP-1 were only found in the 3d group compared with normal control (NC) group (all p < .05). In REC-AN group, CT/p-JNK1 or AQP-1 in 3d group was significantly higher than that in other 3d groups (all p < .05), but no significant difference in refractive error or AL was found compared with NC group at three time points (all p > .05). In REC-SP group, a significant difference in refractive error/CT/p-JNK1 or AQP1 was found in 3d/7d group compared with NC group (all p < .05), but AL was only found in 3d groups (p = .001).

Conclusions

Changes in JNK1 phosphorylation can regulate AQP-1 and CT during the recovery from myopia and the recovery time. Thus, JNK1 may be a potential therapeutic target for preventing/treating myopia.

Acknowledgments

The authors wish to acknowledge the support of Peng Hao MD, Bin Wu MD, Yu Chuan Wang MD, Jing Li MD, Ruifang Han MD, Ze Yu Liang MD, Ming Ying MD at the Tianjin Eye Hospital, Nankai University Affiliated Eye Hospital, Clinical College of Ophthalmology.

The authors disclose that this manuscript was edited by AJE and a preprint is available on a server run by Research Square (https://www.researchsquare.com/article/rs-19152/v2).

Declaration of interest

Wei Chen, None; Zhiwei Li, None; Qimiao Wang, None; Yan Wang, None; Yue Zhang, None.

Additional information

Funding

This work were supported by the Tian Jin Science Foundation of China under Grant 17JCYBJC26900; The Tian Jin Health Commission of China under Grant 2019110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.